Changing bone patterns with progression of chronic kidney disease

Area of Science:

• Nephrology
• Endocrinology
• Bone Metabolism

Background:

• Renal osteodystrophy is common in chronic kidney disease (CKD).
• Osteitis fibrosa (high turnover) and mixed uremic osteodystrophy (mineralization defect) are considered predominant forms.
• Emerging evidence suggests adynamic bone disease (low turnover) may occur earlier in CKD.

Purpose of the Study:

• To investigate the potential early occurrence of adynamic bone disease in CKD.
• To explore the mechanisms underlying the transition from low- to high-turnover bone disease in CKD patients.

Main Methods:

• Review of existing literature on renal osteodystrophy in CKD.
• Analysis of factors contributing to bone turnover regulation in CKD.
• Discussion of molecular pathways involved in bone remodeling.

Main Results:

• Adynamic bone disease, characterized by low bone turnover, may be the initial bone manifestation in a significant proportion of early CKD patients.
• Factors such as PTH resistance, low calcitriol, hormone deficiencies, diabetes, and uremic toxins (inhibiting Wnt/β-catenin signaling) contribute to low bone turnover.
• High-turnover bone disease may develop later as PTH levels rise and overcome inhibitory factors.

Conclusions:

• The traditional view of predominant high-turnover renal osteodystrophy may not apply to early CKD stages.
• Understanding the transition from low- to high-turnover bone disease is crucial for managing CKD-mineral and bone disorder.
• Further research is needed to clarify the roles of FGF23 and Klotho in this transition.